Vitti G, Hamilton J A
University of Melbourne, Department of Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Arthritis Rheum. 1988 Aug;31(8):1046-51. doi: 10.1002/art.1780310817.
Previous studies have shown that mononuclear cell-conditioned medium (MCCM), interleukin-1 (IL-1), and all-trans-retinoic acid rapidly stimulate, while glucocorticoids lower, the urokinase-type plasminogen activator (u-PA) activity of human synovial fibroblast-like cells. It is now reported that MCCM, recombinant human IL-1 alpha (rHuIL-1 alpha), rHuIL-1 beta, and all-trans-retinoic acid elevate the u-PA messenger RNA (mRNA) levels to a steady-state value within 2 hours, while dexamethasone (10(-7)M) inhibits this increase. For both situations, when the u-PA activity is either stimulated or reduced, the changes in the u-PA mRNA levels parallel the changes in the u-PA activity, and it is suggested that modulation of gene transcription plays an important role.
先前的研究表明,单核细胞条件培养基(MCCM)、白细胞介素-1(IL-1)和全反式维甲酸可迅速刺激人滑膜成纤维样细胞的尿激酶型纤溶酶原激活剂(u-PA)活性,而糖皮质激素则会降低该活性。现在有报道称,MCCM、重组人IL-1α(rHuIL-1α)、rHuIL-1β和全反式维甲酸可在2小时内将u-PA信使核糖核酸(mRNA)水平提高到稳态值,而地塞米松(10^(-7)M)则抑制这种升高。对于这两种情况,当u-PA活性受到刺激或降低时,u-PA mRNA水平的变化与u-PA活性的变化平行,提示基因转录的调节起重要作用。